Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
22.00    -0.14 (-0.62%)
Bid:
22.02
Ask:
23.10
Spread: 1.08 (4.905%)
Market Cap: €121.93b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Issue of preferred securities

8 Jan 2025 07:00

RNS Number : 4862S
Banco Bilbao Vizcaya Argentaria SA
07 January 2025
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the securities market legislation, and further to the inside information dated 26 September 2024 (with registration number 2396), hereby proceeds to notify the following:

 

OTHER RELEVANT INFORMATION

 

 

BBVA has agreed to carry out an issue of preferred securities contingently convertible into newly issued ordinary shares of BBVA with exclusion of pre-emptive subscription rights for shareholders (the "Securities") for a total nominal amount of 1,000,000,000 US Dollars (the "Issuance").

 

Once fully paid-up, the Securities are expected to qualify as Additional Tier 1 Capital of BBVA and its Group pursuant to the applicable solvency regulations.

 

Distributions on the Securities, whose payment is discretionary and subject to certain conditions, will accrue at a rate of 7.75% per annum from and including 14 January 2025 to but excluding 14 January 2032. After that, the distribution rate will be reset in accordance with the applicable terms and conditions of the Issuance by applying a margin of 324.9 basis points on the 5-year UST.

 

The Issuance is in no event directed towards retail investors, without prejudice to the additional sales restrictions set out in the terms and conditions of the Issuance.

 

BBVA will request the listing of the Securities on the New York Stock Exchange (NYSE).

 

Furthermore, BBVA informs that, for the purposes set forth in articles 414, 417, 510 and 511 of the Spanish Corporate Enterprises Act (Ley de Sociedades de Capital), the director's report and the report of the independent expert/auditor of accounts different from BBVA's auditor, both related to the Issuance, have been issued. These reports will be available to shareholders through their publication on BBVA's website (www.bbva.com) on the Issuance closing date (expected to take place on 14 January 2025) and will be reported to the first General Shareholders' Meeting to be held after the Issuance.

 

 

Madrid, 7 January 2025

 

 

 

 

 

Important information:

There are restrictions with respect to the offering of the Securities in various jurisdictions, including the United Kingdom, Spain, Singapore, Hong Kong, Canada, Switzerland and the European Economic Area.

This document may not be distributed, directly or indirectly, in any jurisdiction in which said distribution is contrary to applicable laws.

This document is not a prospectus and is not an offer or a solicitation to buy, sell, subscribe or exchange any securities issued or to be issued by BBVA. No such offer in relation to the Securities shall be conducted in any jurisdiction in which said offer is not made in conformity with the applicable legislation.

This document is not an offer for sale of securities in the United States.

In relation with the Issuance, BBVA has filed a registration statement (including a prospectus), and a prospectus supplement with the U.S. Securities and Exchange Commission (the "SEC"). Before you invest, you should read the prospectus and prospectus supplement included in that registration statement and the other documents BBVA has filed with the SEC for more complete information about BBVA and the Issuance. You may obtain these documents for free by visiting the SEC web site at www.sec.gov.

This announcement is not a prospectus, and investors should not purchase any Securities except on the basis of the information contained in the prospectus, the prospectus supplement and the other documents filed by BBVA with the SEC that are incorporated by reference in the registration statement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAAFXEELSEAA
Date   Source Headline
6th Jul 202610:32 amRNSPeriodic Report on the Buyback Program 06/07/2026
1st Jul 202610:18 amRNSPeriodic Report on the Buyback Program 01/07/2026
24th Jun 20265:55 pmRNSOIR - Capital reduction
22nd Jun 202610:10 amRNSPeriodic Report on the Buyback Program 22/06/2026
15th Jun 202610:14 amRNSPeriodic Report on the Buyback Program 15/06/2026
9th Jun 20265:09 pmRNSOIR redemption GMTN 167 (T2)
8th Jun 202610:19 amRNSPeriodic Report on the Buyback Program 08/06/2026
1st Jun 202610:20 amRNSPeriodic Report on the Buyback Program 01/06/2026
26th May 20267:00 amRNSPeriodic Report on the Buyback Program 25/05/2026
18th May 202610:18 amRNSPeriodic Report on the Buyback Program 18/05/2026
12th May 20266:23 pmRNSHR - Fitch rating upgrade
11th May 202610:17 amRNSPeriodic Report on the Buyback Program 11/05/2026
1st May 20267:00 amRNSIssue of preferred sec. contingently convertible
1st May 20267:00 amRNSChanges in BBVA’s Board of Directors
30th Apr 20268:39 amRNSShare Buyback Program
30th Apr 20267:19 amRNS1Q26 Earnings Presentation
30th Apr 20267:16 amRNS1Q26 Quarterly Report
30th Apr 20267:12 amRNSResults Press Release BBVA 1T2026
22nd Apr 20261:24 pmRNS1T26 Earnings Presentation Announcement
20th Apr 20267:00 amRNSCompletion of the execution of the Second Tranche
17th Apr 20267:14 amRNSEarly redemption of public sector covered bonds
15th Apr 20262:57 pmRNSBBVA Notice to amend final terms GMTN 29
14th Apr 20265:20 pmRNSMREL requirement
13th Apr 202610:19 amRNSPeriodic Report on the Buyback Program 13/04/2026
7th Apr 20267:00 amRNSPeriodic Report on the Buyback Program 06/04/2026
31st Mar 20265:50 pmRNSBBVAs share capital reduction
23rd Mar 20267:00 amRNSPilar 3 Report 2025
20th Mar 202611:50 amRNSShare Buyback Program
6th Mar 20266:19 pmRNSCompletion of the execution of the First Tranche
2nd Mar 202610:18 amRNSPeriodic Report on the Buyback Program 2026/03/02
23rd Feb 202610:29 amRNSPeriodic Report on the Buyback Program 23/02/2026
19th Feb 202610:46 amRNS2025_Individual_Annual_Accounts_and_Management_Rep
19th Feb 202610:37 amRNS2025_Cons_Annual_Accounts_and_Management_Report
16th Feb 202610:24 amRNSPeriodic Report on the Buyback Program 2026/02/16
13th Feb 20265:22 pmRNSApril dividend calendar
13th Feb 20263:33 pmRNS2026 AGM Notice and Proposed Resolutions
11th Feb 20265:44 pmRNSEarly redemption of Senior Preferred Notes
10th Feb 20267:00 amRNS2026 Annual General Meeting Call
9th Feb 202610:11 amRNSPeriodic Report on the Buyback Program 2026/02/09
5th Feb 20267:00 amRNS4Q25 Earnings Report
5th Feb 20267:00 amRNSShareholder remuneration for 2025
5th Feb 20267:00 amRNS4Q25 Earnings Presentation
5th Feb 20267:00 amRNS4Q25 Earnings Press Release
2nd Feb 202610:27 amRNSPeriodic Report on the Buyback Program 02/02/2026
28th Jan 20261:29 pmRNS4Q25 Earnings Presentation Announcement
27th Jan 20267:00 amRNSNew Periodic Report Buyback Program 26/01/2026
26th Jan 202610:30 amRNSPeriodic Report on the Buyback Program 26/01/2026
19th Jan 202610:06 amRNSPeriodic Report on the Buyback Program 19/01/2026
12th Jan 202610:18 amRNSPeriodic Report on the Buyback Program 12/01/2026
2nd Jan 202610:39 amRNSPeriodic Report on the Buyback Program 02/01/2026

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.